Protalix BioTherapeutics
PLX
#8933
Rank
โ‚ฌ0.16 B
Marketcap
2,07ย โ‚ฌ
Share price
0.42%
Change (1 day)
54.45%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): โ‚ฌ17.97 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are โ‚ฌ76.38 Million. In 2025 the company made an earning of -โ‚ฌ3.73 Million a decrease over its 2024 earnings that were of โ‚ฌ4.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ17.97 M-583.06%
2025 -โ‚ฌ3.73 Million-181.6%
2024 โ‚ฌ4.56 M-55.62%
2023 โ‚ฌ10.27 M-199.05%
2022 -โ‚ฌ10.38 Million-40.38%
2021 -โ‚ฌ17.41 Million-732.31%
2020 โ‚ฌ2.75 M-130.53%
2019 -โ‚ฌ9.02 Million189.85%
2018 -โ‚ฌ3.12 Million-95.29%
2017 -โ‚ฌ66.07 Million308.12%
2016 -โ‚ฌ16.19 Million-32.37%
2015 -โ‚ฌ23.94 Million10.11%
2014 -โ‚ฌ21.74 Million-7.59%
2013 -โ‚ฌ23.53 Million
2011 -โ‚ฌ27.24 Million-19.39%
2010 -โ‚ฌ33.8 Million20.87%
2009 -โ‚ฌ27.96 Million32.26%
2008 -โ‚ฌ21.14 Million-5.46%
2007 -โ‚ฌ22.36 Million
2004 -โ‚ฌ0.15 Million12.35%
2003 -โ‚ฌ0.13 Million-11.1%
2002 -โ‚ฌ0.15 Million-57.03%
2001 -โ‚ฌ0.34 Million1.03%
2000 -โ‚ฌ0.34 Million-53.22%
1999 -โ‚ฌ0.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.26 B 50,808.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.69 B 3,739.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.16 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.98 B 10,816.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel